(Q40143078)

English

Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme

scientific article published on January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 September 2017

Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme (English)

1 reference

Europe PubMed Central

17 September 2017

1 reference

based on heuristic

inferred from title

author name string

Su FH

1

1 reference

Europe PubMed Central

17 September 2017

Chen JD

2

1 reference

Europe PubMed Central

17 September 2017

Cheng SH

3

1 reference

Europe PubMed Central

17 September 2017

Sung KY

4

1 reference

Europe PubMed Central

17 September 2017

Jeng JJ

5

1 reference

Europe PubMed Central

17 September 2017

Chu FY

6

1 reference

Europe PubMed Central

17 September 2017

publication date

1 January 2008

1 reference

Europe PubMed Central

17 September 2017

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

17 September 2017

15

1 reference

Europe PubMed Central

17 September 2017

14-19

1 reference

Europe PubMed Central

17 September 2017

1

1 reference

Europe PubMed Central

17 September 2017

Chronic hepatitis B virus infection in Asian countries

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00890.X

21 January 2018

The discovery of the hepatitis viruses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00890.X

21 January 2018

Strategies to prevent and control hepatitis B and C virus infections: a global perspective

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00890.X

21 January 2018

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00890.X

21 January 2018

Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00890.X

21 January 2018

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00890.X

21 January 2018

Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00890.X

21 January 2018

Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00890.X

21 January 2018

A mass hepatitis B vaccination programme in Taiwan: its preparation, results and reasons for uncompleted vaccinations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00890.X

21 January 2018

Ten-year follow-up study of neonatal hepatitis B immunization: are booster injections indicated?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00890.X

21 January 2018

Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00890.X

21 January 2018

Scheduling of revaccination against hepatitis B virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00890.X

21 January 2018

Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00890.X

21 January 2018

Are booster immunisations needed for lifelong hepatitis B immunity?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00890.X

21 January 2018

The long-term efficacy of plasma-derived hepatitis B vaccine in babies born to carrier mothers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00890.X

21 January 2018

Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00890.X

21 January 2018

Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00890.X

21 January 2018

Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00890.X

21 January 2018

Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00890.X

21 January 2018

A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00890.X

21 January 2018

Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in taiwan

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00890.X

21 January 2018

Identifiers

10.1111/J.1365-2893.2007.00890.X

1 reference

Europe PubMed Central

17 September 2017

1 reference

Europe PubMed Central

17 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40143078&oldid=1886780674"